Form 4: VolitionRx Director Innes Acquires 174,764 Shares in Direct Offering

VolitionRx director Guy Archibald Innes acquired 174,764 shares of common stock at $0.5722 per share through a registered direct offering.

Summary

• Guy Archibald Innes, a director at VolitionRx Ltd, acquired 174,764 shares of common stock on December 9, 2024.
• The shares were purchased at a price of $0.5722 per share through a registered direct offering.
• Following the transaction, Mr. Innes directly owns 617,085 shares of VolitionRx.
• Mr. Innes also has indirect beneficial ownership of 1,400,000 shares through The Innes Family Bare Trust 2023, 356,000 shares through The Dill Faulkes Educational Trust Limited, and 154,503 shares each through two sons and 154,504 shares each through two daughters.

Sentiment

Score: 6

Explanation: The document is a routine filing of a share purchase by a director. While the purchase could be seen as a positive sign, it's not a major event that would significantly impact sentiment.

Positives

• The director's purchase of shares could be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders when they buy or sell shares. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider trading.
• The transaction is typical for directors who may participate in direct offerings or other share purchase programs.

Stakeholder Impact

• The share purchase by a director may be viewed positively by shareholders, indicating confidence in the company.

Key Dates

Keywords

VolitionRx, Director, Share Acquisition, Direct Offering, Beneficial Ownership, VNRX, Guy Archibald Innes